Added to YB: 2025-05-14
Pitch date: 2025-05-11
RCEL [neutral]
AVITA Medical, Inc.
-53.24%
current return
Author Info
Steve Wagner provides in-depth analysis of my favorite individual companies. Sign up for the newsletter.
Company Info
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
Market Cap
$149.6M
Pitch Price
$7.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.05
P/E
-2.86
EV/Sales
2.38
Sector
Biotechnology
Category
turnaround
AVITA Medical Q1 2025 Earnings: High Growth, Higher Stakes
RCEL exited position: RECELL spray-on skin maker missed Q1 internal targets ($18.5M revenue vs $20M exp) despite 67% YoY growth. Expanded from burns to $3.5B TAM with new products (RECELL GO mini, Cohealyx, PermeaDerm). Cash concern: $26M left, burning $10M/qtr, narrowly avoided debt covenant breach. Targeting Q4 2025 profitability.
Read full article (7 min)